Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APP: Low-dose Atropine for Myopia Progression
NCT03911271Phase 2Completed
- Start
- May 2019
- Primary completion
- Apr 2024
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of atropine in myopia (3 arms). Primary endpoints: Axial Length at 36 Months and Spherical Equivalent at 36 Months. Started May 2019; status: completed.
02
Drugs
atropine
03
Conditions
myopia
Beyond the preview
Go deeper on NCT03911271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03911271.